Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Anklam – page 2

145 clinical trials in Anklam, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Anklam at a glance
145
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

145 trials in Anklam

Open in trial search

Cevostamab, Pomalidomide and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma Previously Treated with 1‑3 Lines of Therapy

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Carfilzomib
  • Sponsor:F. Hoffmann-La Roche AG

Accelerating improvement with teclistamab plus standard drug combination in newly diagnosed transplant‑eligible multiple myeloma patients

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:Universitaetsklinikum Heidelberg AöR

Cardiac failure+1

Recruiting

Study of Zenagamtide (NNC0487-0111) versus placebo in patients with heart failure with preserved or mildly reduced ejection fraction and obesity

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Zenagamtide
  • Sponsor:Novo Nordisk A/S

A study to evaluate the effectiveness and safety of REGN13335 in adults with pulmonary arterial hypertension

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Vasigrobart
  • Sponsor:Regeneron Pharmaceuticals Inc.

A study to evaluate the safety and effectiveness of inhaled treprostinil in patients with pulmonary hypertension associated with interstitial lung disease

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Treprostinil
  • Sponsor:Liquidia Technologies Inc.

A study testing how well AZD4144 works and how safe it is for adults with acute kidney injury caused by sepsis

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:AZD4144
  • Sponsor:AstraZeneca AB

A study of bleximenib combined with intensive chemotherapy for adults with newly diagnosed acute myeloid leukemia with specific genetic changes.

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bleximenib
  • Sponsor:Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting

A Study of Acoramidis in Adult Patients with Transthyretin Amyloidosis with Cardiomyopathy Who Previously Received Tafamidis

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Acoramidis
  • Sponsor:Bayer Consumer Care AG

Testing Stem Cell Transplant Methods and Medications Including Ruxolitinib and Blinatumomab for Children and Young Adults with Acute Lymphoblastic Leukemia

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years
  • Substances:Blinatumomab
  • Sponsor:Ospedale Pediatrico Bambino Gesu

A Study of Amivantamab and Lazertinib for Adults with EGFR-Mutated Advanced or Metastatic Non-Small Cell Lung Cancer

InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Amivantamab
  • Sponsor:Janssen Cilag International

A study of LTP001 in combination with standard treatment for adults with pulmonary arterial hypertension

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:LTP001
  • Sponsor:Novartis Pharma AG

Study comparing standard and reduced intensity treatment in patients with acute myeloid leukemia or chronic lymphocytic leukemia who have no detectable disease after initial therapy

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Busulfan
  • Sponsor:Medizinische Hochschule Hannover

Other cities in Germany

The busiest research cities in the country

All 505 cities in Germany

Clinical research in Anklam

What the registry says about research in the country

01 Rheumatology Research

Innovative clinical trials focusing on acute gout management are evaluating different treatment approaches for patients experiencing severe attacks. This research aims to compare the effectiveness of traditional and alternative therapeutic options in primary care settings.

  • Pain Management Assessment
  • Acute Gout Treatment
  • Primary Care Integration

The research employs advanced pain measurement techniques to evaluate treatment outcomes, contributing to improved patient care protocols in rheumatological conditions.

02 Pain Management Studies

Comprehensive research into pain control methodologies for inflammatory conditions, utilizing standardized numerical rating scales to assess treatment effectiveness. These trials are designed to enhance our understanding of pain management in acute conditions.

  • Numerical Pain Assessment
  • Treatment Comparison
  • Patient Response Monitoring

The studies aim to establish more effective protocols for managing severe pain episodes in inflammatory arthritis conditions.

03 Clinical Therapeutics

Investigation of therapeutic alternatives for inflammatory conditions, comparing established medications through rigorous clinical evaluation. This research focuses on determining optimal treatment strategies for acute inflammatory episodes.

  • Medication Efficacy
  • Treatment Optimization
  • Clinical Outcomes

These trials contribute to developing evidence-based treatment guidelines for primary care practitioners.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.